Biogen says Tecfidera data confirms efficacy
Posted: Tue Apr 19, 2016 12:51 am
Biogen has unveiled new Tecfidera research that, it says, reinforces its efficacy in newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients and further supports its long-term, well-characterised safety profile. The data was presented at the 68th annual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada...Read More - http://www.ms-uk.org/MSnews